Lincoln Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2025 ,inter alia, to consider and approve Audited (standalone ....
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lincoln Pharmaceuticals has informed exchanges that its Board of Directors will meet on Thursday, May 22, 2025. The agenda includes considering and approving the audited standalone and consolidated financial results for the quarter and full year ended March 31, 2025. The Board will also consider recommending a dividend on equity shares, if any. The trading window for dealing in company securities, which closed on April 1, 2025, will remain shut until 48 hours after the results are made public.
This is a routine pre-results announcement with no financial numbers disclosed yet. Investors should watch for the FY25 results and any dividend declaration on May 22, which could be a near-term catalyst for the stock.